Bioengineering: Heart, Lung, Blood & Sleep Disorders


Bold New Bioengineering Methods and Approaches for Heart, Lung, Blood and Sleep Disorders and Diseases

The purpose of this funding opportunity announcement (FOA) is to seek innovative, high-risk bioengineering research for which preliminary results have not yet been obtained, explore new approaches or concepts that are important to a substantive heart, lung, blood or sleep disorder or disease, support the translation of research into practice, technologies, or commercial products, and to develop trans-disciplinary projects upon which significant future research may be built.  This  program will allow investigators to enter new fields and apply cutting-edge approaches to improve the Nation’s health through bioengineering research.  In particular, ground-breaking studies aimed towards the development of novel agents, materials or coatings related to medical devices and engineered tissues would be uniquely fostered by this FOA.


  • Pre-Application Submission: 30 days before application submission due date
  • Application Submission: 5:00 PM local time of applicant organization, Jan. 10, 2017; May 10, 2017; Oct. 13, 2017; Jan. 10, 2018; May 10, 2018; Oct. 13, 2018; Jan. 10, 2019; May 10, 2019


Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.